Designing chocolate, not aspirin
28
-
Upload
alexandra-deschamps-sonsino -
Category
Design
-
view
106 -
download
2
description
Talk given at the Ideo Make-a-thon in Munich on July 6th 2013.
Transcript of Designing chocolate, not aspirin
Tinker London 2007-2010
Good Night Lamp March 2012
First UK distributor of the Arduino
R&D projects for corporates
A family of internet-connected
lamps.
IDII 2004-2006
#iot The internet of things can be loosely
defined as:
1. what happens when we embed connectivity in everyday objects.
2. what happens when those objects are designed with an understanding
of the affordances of the web.
the shape of the conversation
Hardware (open/closed)
Connectivity
(wifi, zigbee/radio, GSM)
Battery life
Standards
Privacy
Security
What things?
What things?
Smart cities
Smart cars
Home automation
Products as part of an ecology.
3 approaches.
1. Design to extend. 2. Design to comfort. 3. Design to disrupt.
Your product extends the capabilities of an existing device. It’s tethered to a screen. If connectivity is lost, the object becomes unusable because its control interface is inaccessible. Non-objects, more like accessories.
Design to extend.
Nike +
Green Goose
CubeSensors
Olly & Molly
Piggy-back on an existing product and augment it with connectivity. Technology is invisible so everything looks normal. This is Big Brother territory. You may be redefining a user’s assumptions about a product.
Design to comfort (or trouble).
Ambiant Umbrella
Calypso Key
Develop a design language that is unique to users’ interaction with a new technology. Developing a new visual language consumers. Develop a new space in retail.
Design to disrupt.
Google Glass
Nabaztag
Fitbit
Points
Good Night Lamp
BleepBleeps
Little Printer
Uncanny valley of products.
gadget object
iot
Delight sells.
Retail & invention is changing.
Sometimes about hockey sticks or watches.
Delight is harder
Retail spaces will change to accommodate story-telling. Consumers love it if it’s clearly useful or clearly beautiful. Delight might not get you funded but it will get people talking.
![ADD-ASPIRIN: A phase III, double-blind, placebo … the use of aspirin and cancer risk [2]. A meta-analysis of ... The Add-Aspirin trial aims to assess whether regular aspirin use](https://static.fdocuments.in/doc/165x107/5ab88fee7f8b9ad5338cf365/add-aspirin-a-phase-iii-double-blind-placebo-the-use-of-aspirin-and-cancer.jpg)
